|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 78.64 INR | -2.30% |
|
-3.84% | +46.63% |
Company Valuation: Colinz Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 40.82 | 34.74 | 107.6 | 160 | 94.59 | 182.5 |
| Change | - | -14.89% | 209.87% | 48.62% | -40.87% | 92.92% |
| Enterprise Value (EV) 1 | 18.65 | -2.149 | 60.43 | 105.4 | 30.29 | 133.4 |
| Change | - | -111.53% | 2,911.96% | 74.47% | -71.27% | 340.39% |
| P/E | 31.3x | 16.7x | 31.8x | 19.2x | 19.5x | 36.8x |
| PBR | 0.6x | 0.48x | 1.4x | 1.08x | 1.06x | 1.93x |
| PEG | - | 0.3x | 0.5x | 0x | 3.23x | 17.76x |
| Capitalization / Revenue | 0.54x | 0.56x | 1.54x | 2.24x | 1.35x | 2.8x |
| EV / Revenue | 0.25x | -0.03x | 0.87x | 1.47x | 0.43x | 2.04x |
| EV / EBITDA | 6.16x | -0.65x | 10.3x | 16.7x | 5.58x | 26.9x |
| EV / EBIT | 17.3x | -1.52x | 15.7x | 20.9x | 7.34x | 36.7x |
| EV / FCF | 2.68x | -0.2x | 8.87x | 17.8x | 4.12x | -7.62x |
| FCF Yield | 37.3% | -506% | 11.3% | 5.62% | 24.3% | -13.1% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 0.2854 | 0.4541 | 0.74 | 1.82 | 1.93 | 1.97 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 76.03 | 61.59 | 69.74 | 71.55 | 70.3 | 65.28 |
| EBITDA 1 | 3.027 | 3.331 | 5.862 | 6.326 | 5.428 | 4.951 |
| EBIT 1 | 1.079 | 1.418 | 3.85 | 5.037 | 4.125 | 3.639 |
| Net income 1 | 1.304 | 2.076 | 3.393 | 4.574 | 4.867 | 4.966 |
| Net Debt 1 | -22.17 | -36.89 | -47.22 | -54.55 | -64.3 | -49.09 |
| Reference price 2 | 8.93 | 7.60 | 23.55 | 35.00 | 37.55 | 72.44 |
| Nbr of stocks (in thousands) | 4,571 | 4,571 | 4,571 | 4,571 | 2,519 | 2,519 |
| Announcement Date | 02/09/20 | 30/08/21 | 24/08/22 | 29/08/23 | 29/08/24 | 28/08/25 |
1INR in Million2INR
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 20.94L | ||
| 35.81x | 6.76x | 23.37x | 0.81% | 4.84TCr | ||
| 17.97x | 2.03x | 9.59x | 1.33% | 3.5TCr | ||
| 27.22x | 3.3x | 17.11x | 0.84% | 1.16TCr | ||
| 26.4x | 3.9x | 15.87x | 0.6% | 1.15TCr | ||
| 19.11x | 3.34x | 11.98x | 3.48% | 899.16Cr | ||
| 15.88x | 2.04x | 6.86x | 3.27% | 687.77Cr | ||
| 8.14x | 1.9x | 4.98x | 5.33% | 662.25Cr | ||
| 33.47x | 3.81x | 16.2x | 0.24% | 642.57Cr | ||
| Average | 23.00x | 3.39x | 13.25x | 1.99% | 1.5TCr | |
| Weighted average by Cap. | 26.08x | 4.16x | 15.80x | 1.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- COLINZ6 Stock
- Valuation Colinz Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
















